The stock of Edwards Lifesciences Corp (EW) has gone up by 4.03% for the week, with a 0.00% drop in the past month and a -23.88% drop in the past quarter. The volatility ratio for the week is 2.87%, and the volatility levels for the past 30 days are 2.96% for EW. The simple moving average for the last 20 days is 2.12% for EW stock, with a simple moving average of -15.79% for the last 200 days.
Is It Worth Investing in Edwards Lifesciences Corp (NYSE: EW) Right Now?
The price-to-earnings ratio for Edwards Lifesciences Corp (NYSE: EW) is above average at 28.04x, Company’s 36-month beta value is 1.12.Analysts have differing opinions on the stock, with 9 analysts rating it as a “buy,” 7 as “overweight,” 4 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for EW is 592.02M, and currently, short sellers hold a 1.62% ratio of that floaft. The average trading volume of EW on October 14, 2024 was 6.95M shares.
EW) stock’s latest price update
Edwards Lifesciences Corp (NYSE: EW)’s stock price has plunge by -0.19relation to previous closing price of 68.26. Nevertheless, the company has seen a 4.03% surge in its stock price over the last five trading sessions. accesswire.com reported 2024-10-11 that NEW YORK, NY / ACCESSWIRE / October 11, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Edwards Lifesciences Corporation (“Edwards Lifesciences”) (NYSE:EW) concerning possible violations of federal securities laws. On October 28, 2022, Edwards announced 3Q 2022 financial results that missed revenue estimates and then lowered revenue guidance for the 4Q.
Analysts’ Opinion of EW
Many brokerage firms have already submitted their reports for EW stocks, with Morgan Stanley repeating the rating for EW by listing it as a “Equal-Weight.” The predicted price for EW in the upcoming period, according to Morgan Stanley is $70 based on the research report published on October 11, 2024 of the current year 2024.
Jefferies, on the other hand, stated in their research note that they expect to see EW reach a price target of $70, previously predicting the price at $85. The rating they have provided for EW stocks is “Hold” according to the report published on September 18th, 2024.
EW Trading at 1.76% from the 50-Day Moving Average
After a stumble in the market that brought EW to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -29.12% of loss for the given period.
Volatility was left at 2.96%, however, over the last 30 days, the volatility rate increased by 2.87%, as shares sank -0.57% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +10.14% upper at present.
During the last 5 trading sessions, EW rose by +4.03%, which changed the moving average for the period of 200-days by -10.68% in comparison to the 20-day moving average, which settled at $66.71. In addition, Edwards Lifesciences Corp saw -10.65% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at EW starting from BOBO DONALD E JR, who sale 5,000 shares at the price of $66.77 back on Sep 11 ’24. After this action, BOBO DONALD E JR now owns 46,936 shares of Edwards Lifesciences Corp, valued at $333,826 using the latest closing price.
Chopra Daveen, the CVP, TMTT of Edwards Lifesciences Corp, sale 1,250 shares at $69.95 during a trade that took place back on Aug 20 ’24, which means that Chopra Daveen is holding 29,333 shares at $87,438 based on the most recent closing price.
Stock Fundamentals for EW
Current profitability levels for the company are sitting at:
- 0.27 for the present operating margin
- 0.77 for the gross margin
The net margin for Edwards Lifesciences Corp stands at 0.25. The total capital return value is set at 0.18. Equity return is now at value 21.35, with 15.44 for asset returns.
Based on Edwards Lifesciences Corp (EW), the company’s capital structure generated 0.08 points at debt to capital in total, while cash flow to debt ratio is standing at 1.4. The debt to equity ratio resting at 0.08. The interest coverage ratio of the stock is 58.31.
Currently, EBITDA for the company is 1.95 billion with net debt to EBITDA at -0.55. When we switch over and look at the enterprise to sales, we see a ratio of 6.68. The receivables turnover for the company is 7.19for trailing twelve months and the total asset turnover is 0.59. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.71.
Conclusion
In a nutshell, Edwards Lifesciences Corp (EW) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
